This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Memorial Sloan Kettering Cancer Center, Takeda Pharmaceutical Company Limited. Active years: 2018-2026.
Company Filing History:
3 out of 617 
1 out of 1,224 
Years Active: 2018-2026
Title: Innovations in Cancer Treatment by George Plitas
Introduction
George Plitas is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the area of immunotherapy. With a total of 3 patents, his work focuses on innovative methods for diagnosing and treating cancer.
Latest Patents
One of his latest patents is centered around depleting tumor-specific regulatory T cells (Tregs). This invention provides methods and compositions for diagnosing and treating cancer by targeting CCR8. The technology aims to deplete Treg cells, especially those that infiltrate tumors, thereby enhancing the effectiveness of cancer treatments.
Career Highlights
George Plitas is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His work at this prestigious center allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer therapy.
Collaborations
One of his notable coworkers is Alexander Rudensky, who is also a prominent figure in cancer research. Their collaboration exemplifies the importance of teamwork in advancing scientific knowledge and developing effective cancer treatments.
Conclusion
George Plitas continues to be a vital contributor to cancer research through his innovative patents and collaborations. His work holds promise for improving cancer treatment outcomes and enhancing patient care.